RxDoctor Payments Data

Carolina Cabrera

New York, NYNPI 1396451159

Payments from drug & device makers

$6,010in general payments, 2019–2025

Across 247 payments — averaging $24.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Arcutis Biotherapeutics, Inc.$480
  • Johnson & Johnson$474
  • Sanofi$401
  • E.r. Squibb & Sons, L.L.C.$369
  • UCB, Inc.$330
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$5,986100%
  • Education$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinonide34$2,664
Clobetasol Propionate22$1,258
Ketoconazole30$618
Triamcinolone Acetonide30$314
Hydrocortisone17$177

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →